|Former Common name||TL9 KO (B6N)|
|ES Cell line|
|Strain development||Developed by Koji Ikegami and Mitsutoshi Setou, Mitsubishi Kagaku Institute of Life Sciences. C57BL/6N derived ES cells were used. The mice were crossed to C57BL/6N.|
|Strain description||Ttll9 (TL9) gene knockout mice. Exons 4 and 5 were replaced with neo cassette. A region including an initiation site of TTL domain was removed. Initiation codon is in exon 1. Null type mutant. Homozygous mutant male mice are infertile.|
|Colony maintenance||Heterozygote x Wild-type [C57BL/6NJcl]|
|Examination Date / Room / Rack||No Data|
Gene symbolGene nameChr.Allele symbolAllele namePromoter
Ttll9tubulin tyrosine ligase-like family, member 92Ttll9<tm1Seto>targeted mutation 1, Mitsutoshi Setou
|Donor DNA||Ttll9 genomic DNA (mouse), neo (E. coli)|
|Specific Term and Conditions||The BIOLOGICAL RESOURCE shall be used only for academic research purposes by|
a non-profit organization.
The RECIPIENT of a non-profit organization must prior contact RIKEN BRC and
negotiate with Mitsubishi Chemical Corporation to use the BIOLOGICAL
RESOURCE for purposes of other than academic research.
In publishing the research results to be obtained by use of the BIOLOGICAL
RESOURCE in relevant journals and meetings, the RECIPIENT must stipulate the
source of the BIOLOGICAL RESOURCE and an acknowledgment to Mitsubishi
The RECIPIENT agrees that RIKEN BRC informs annually to Mitsubishi Chemical
Corporation of RECIPIENT organization, RECIPIENT name, the specific research
purpose and the date of distribution.
|Depositor||Mitsutoshi Setou (Mitsubishi Kasei Institute of Life Sciences)|
|Strain Status||Frozen embryos|
|Strain Availability||Recovery and QC required prior to distribution|
BRC mice in Publications